Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1984 Mar;68(3):182–187. doi: 10.1136/bjo.68.3.182

Pathogenesis of Mooren's ulcer: some new concepts.

P I Murray, A H Rahi
PMCID: PMC1040283  PMID: 6230102

Abstract

Mooren's ulcer is a chronic, painful corneal ulceration of unknown aetiology. Recent histological and immunological studies suggest an autoimmune basis. It is now becoming clear that the immune system plays an intricate role in maintaining homoeostasis in health and disease. Regulation of the immune response appears to involve a subset of peripheral blood T lymphocytes known as suppressor cells. A qualitative or quantitative deficiency of suppressor cells may therefore be responsible for chronic inflammation, autoimmune disease, and immunodeficiency states. To explain the reported immunological aberrations the number of suppressor T cells in addition to other immunological parameters were studied in a patient with bilateral Mooren's ulcers. A deficiency of suppressor T cells was found in the peripheral blood. This deficit in the immunoregulatory mechanism explains some of the immunological abnormalities reported in previous studies. Furthermore this study provides additional evidence for an autoimmune aetiology. In the light of these findings the possibility of a new line of treatment has been raised.

Full text

PDF
184

Images in this article

185Image
on p.185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Sagawa A., Pascual E., Hebert J., Sadeghee S. Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol. 1976 Sep;6(2):192–199. doi: 10.1016/0090-1229(76)90110-0. [DOI] [PubMed] [Google Scholar]
  2. Ahmed A., Wong D. M., Thurman G. B., Low T. L., Goldstein A. L., Sharkis S. J., Goldschneider I. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci. 1979;332:81–94. doi: 10.1111/j.1749-6632.1979.tb47100.x. [DOI] [PubMed] [Google Scholar]
  3. Berkowitz P. J., Arentsen J. J., Felberg N. T., Laibson P. R. Presence of circulating immune complexes in patients with peripheral corneal disease. Arch Ophthalmol. 1983 Feb;101(2):242–245. doi: 10.1001/archopht.1983.01040010244012. [DOI] [PubMed] [Google Scholar]
  4. Brown S. I. Mooren's ulcer. Histopathology and proteolytic enzymes of adjacent conjunctiva. Br J Ophthalmol. 1975 Nov;59(11):670–674. doi: 10.1136/bjo.59.11.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown S. I. What is Mooren's ulcer? Trans Ophthalmol Soc U K. 1978 Sep;98(3):390–392. [PubMed] [Google Scholar]
  6. Butler M., Atherton D., Levinsky R. J. Quantitative and functional deficit of suppressor T cells in children with atopic eczema. Clin Exp Immunol. 1982 Oct;50(1):92–98. [PMC free article] [PubMed] [Google Scholar]
  7. Char D. H., Brunn J., West W. Thymus-derived lymphocytes in the Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 1977 Feb;16(2):179–181. [PubMed] [Google Scholar]
  8. Chretien P. B., Lipson S. D., Makuch R. W., Kenady D. E., Cohen M. H. Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy. Ann N Y Acad Sci. 1979;332:135–147. doi: 10.1111/j.1749-6632.1979.tb47107.x. [DOI] [PubMed] [Google Scholar]
  9. Costanzi J., Daniels J., Thurman G., Goldstein A., Hokanson J. Clinical trials with thymosin. Ann N Y Acad Sci. 1979;332:148–159. doi: 10.1111/j.1749-6632.1979.tb47108.x. [DOI] [PubMed] [Google Scholar]
  10. Cowling P., Ebringer R., Ebringer A. Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis. 1980 Dec;39(6):545–549. doi: 10.1136/ard.39.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dgani R., Czernobilsky B., Lancet M., Borenstein R. Possible ovulation during an ovarian pregnancy. Isr J Med Sci. 1979 Jul;15(7):601–606. [PubMed] [Google Scholar]
  12. Foster C. S., Kenyon K. R., Greiner J., Greineder D. K., Friedland B., Allansmith M. R. The immunopathology of Mooren's ulcer. Am J Ophthalmol. 1979 Aug;88(2):149–159. doi: 10.1016/0002-9394(79)90459-8. [DOI] [PubMed] [Google Scholar]
  13. Frazer I. H., Mackay I. R. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus. Clin Exp Immunol. 1982 Oct;50(1):107–114. [PMC free article] [PubMed] [Google Scholar]
  14. Goldstein A. L., Cohen G. H., Rossio J. L., Thurman G. B., Brown C. N., Ulrich J. T. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am. 1976 May;60(3):591–606. doi: 10.1016/s0025-7125(16)31900-9. [DOI] [PubMed] [Google Scholar]
  15. Goldstein A. L., Low T. L., Thurman G. B., Zatz M. M., Hall N., Chen J., Hu S. K., Naylor P. B., McClure J. E. Current status of thymosin and other hormones of the thymus gland. Recent Prog Horm Res. 1981;37:369–415. doi: 10.1016/b978-0-12-571137-1.50012-8. [DOI] [PubMed] [Google Scholar]
  16. Heredia C. D., Vich J. M., Huguet J., García-Calderón J. V., García-Calderón P. A. Altered cellular immunity and suppressor cell activity in patients with primary retinitis pigmentosa. Br J Ophthalmol. 1981 Dec;65(12):850–854. doi: 10.1136/bjo.65.12.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miller A. E., Hudson J., Tindall R. S. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population. Ann Neurol. 1982 Oct;12(4):341–347. doi: 10.1002/ana.410120405. [DOI] [PubMed] [Google Scholar]
  18. Mondino B. J., Brown S. I., Rabin B. S. Autoimmune phenomena of the external eye. Ophthalmology. 1978 Aug;85(8):801–817. doi: 10.1016/s0161-6420(78)35618-9. [DOI] [PubMed] [Google Scholar]
  19. Mondino B. J., Brown S. I., Rabin B. S. Cellular immunity in Mooren's ulcer. Am J Ophthalmol. 1978 Jun;85(6):788–791. doi: 10.1016/s0002-9394(14)78106-1. [DOI] [PubMed] [Google Scholar]
  20. Nussenblatt R. B., Palestine A. G., Rook A. H., Scher I., Wacker W. B., Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet. 1983 Jul 30;2(8344):235–238. doi: 10.1016/s0140-6736(83)90230-1. [DOI] [PubMed] [Google Scholar]
  21. Nussenblatt R. B., Salinas-Carmona M., Leake W., Scher I. T lymphocyte subsets in uveitis. Am J Ophthalmol. 1983 May;95(5):614–621. doi: 10.1016/0002-9394(83)90379-3. [DOI] [PubMed] [Google Scholar]
  22. Nussenblatt R. B., Salinas-Carmona M., Leake W., Scher I. T lymphocyte subsets in uveitis. Am J Ophthalmol. 1983 May;95(5):614–621. doi: 10.1016/0002-9394(83)90379-3. [DOI] [PubMed] [Google Scholar]
  24. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4061–4065. doi: 10.1073/pnas.76.8.4061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  26. Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17;303(3):125–129. doi: 10.1056/NEJM198007173030303. [DOI] [PubMed] [Google Scholar]
  27. Routhier G., Epstein O., Janossy G., Thomas H. C., Sherlock, Kung P. C., Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet. 1980 Dec 6;2(8206):1223–1226. doi: 10.1016/s0140-6736(80)92481-2. [DOI] [PubMed] [Google Scholar]
  28. Schaap O. L., Feltkamp T. E., Breebaart A. C. Circulating antibodies to corneal tissue in a patient suffering from Mooren's ulcer (ulcus rodens corneae). Clin Exp Immunol. 1969 Oct;5(4):365–370. [PMC free article] [PubMed] [Google Scholar]
  29. Stilma J. S. Conjunctival excision or lamellar scleral autograft in 38 Mooren's ulcers from Sierra Leone. Br J Ophthalmol. 1983 Jul;67(7):475–478. doi: 10.1136/bjo.67.7.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Strelkauskas A. J., Callery R. T., McDowell J., Borel Y., Schlossman S. F. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5150–5154. doi: 10.1073/pnas.75.10.5150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wood T. O., Kaufman H. E. Mooren's ulcer. Am J Ophthalmol. 1971 Jan;71(1 Pt 2):417–422. doi: 10.1016/0002-9394(71)90420-x. [DOI] [PubMed] [Google Scholar]
  32. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES